Anatomy

. All of the following statements about the use of spironolactone in CHF are true except

It should be administered in low doses to prevent hyperkalemial

It affords prognostic benefit in severe hea failure over and above that afforded by ACE inhibitors

It helps to overcome the refractoriness to thiazides

It affords rapid symptomatic relief in CHF patients